Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.

Scientific reports - 19 May 2022

Barbirou Mouadh, Miller Amanda A, Gafni Erik, Mezlini Amel, Zidi Asma, Boley Nathan, Tonellato Peter J

Abstract excerpt

A cell-free DNA (cfDNA) assay would be a promising approach to early cancer diagnosis, especially for patients with dense tissues. Consistent cfDNA signatures have been observed for many carcinogens. Recently, investigations of cfDNA as a reliable early detection bioassay have presented a powerful opportunity for detecting dense tissue screening complications early. We performed a prospective study to evaluate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adaptor Proteins, Signal Transducing
Share to Biological Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biomarkers, Tumor

Share to Breast Neoplasms

Share to Cell-Free Nucleic Acids

Share to Early Detection of Cancer

Share to Mutation

Share to RNA-Binding Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 35589867
DOI: 10.1038/s41598-022-12457-1
PMCID: PMC9120463

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of cfDNA as an early detection assay for dense tissue breast cancer.PMID 35589867Read ↗

Multimodal analysis of cell-free DNA enhances differentiation of early-stage breast cancer from benign lesions and healthy individualsSemantic proximity Read ↗

Circulating cell-free DNA-based epigenetic assay can detect early breast cancerSemantic proximity Read ↗

Discovery and validation of cell-free DNA methylation markers for specific diagnosis, differentiation from benign tumors, and prognosis of breast cancerSemantic proximity Read ↗

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencingSemantic proximity Read ↗

Detection of genomic alterations in breast cancer with circulating tumour DNA sequencing.Semantic proximity Read ↗

Cell-free DNA as a diagnostic marker for cancer: current insightsSemantic proximity Read ↗

The role of ctDNA detection and the potential of the liquid biopsy for breast cancer monitoring.Semantic proximity Read ↗

Cell-free DNA approaches for cancer early detection and interception.Semantic proximity Read ↗

Use of cell free DNA in breast oncology.Semantic proximity Read ↗

Targeted Sequencing of Plasma-Derived vs. Urinary cfDNA from Patients with Triple-Negative Breast CancerSemantic proximity Read ↗

Cell-Free DNA Variables including Gene Mutations in CA15-3 Normal Breast Cancer Reflect Prognosis.Semantic proximity Read ↗

Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.